Among patients with mutant EGFR, carriers of the ADAM9 rs6474526 G allele (TG + GG) demonstrated a significantly increased risk of larger tumor sizes (OR = 2.939, 95% CI = 1.099–7.858; p = 0.025). Here, EGFR is linked to neoplasm.